Recent Pharmaceutical and Biotech Patent Case Law on Infringement Under the Doctrine of Equivalents

The doctrine of equivalents is a judicially-created doctrine that allows a court to find infringement when an accused instrumentality performs substantially the same function in substantially the same way to achieve the same result as the patented invention, or is insubstantially different from the patented invention. This presentation will explore recent case law on the doctrine of equivalents and will include discussions of topics including:

• The continued viability of the doctrine of equivalents as a tool for proving patent infringement;
• Guidance from courts on the successful application of the “function/way/result” and the “insubstantial difference” tests; and
• How limitations on the doctrine of equivalents can influence litigation strategies.

Recorded: View On-Demand

Moderator:
Danielle C. Pfifferling

Speakers:
Justin J. Hasford
Matthew J. Hlinka

Date:
Tuesday, May 12, 2020

Time:
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
19:00 - 20:00 CEST